📜 Post with us on Reddit
📝 Create a new article
🏭 Create a company page
🇬🇧 - in English
🇫🇷 - en Français (FR)
🇵🇹 - em Português (PT)
🇩🇪 - auf Deutsch (DE)
🇯🇵 - 日本語で (JA)
Sponsored articles

You can edit almost every page by Creating an account and confirming your email.

Sameer Jauhar

From EverybodyWiki Bios & Wiki


  • Comment: Lacks multiple references giving significant coverage (more than passing mentions; needs to be in-depth, focused, analytical) about Jauhar in published reliable independent secondary sources. Paul W (talk) 09:39, 4 November 2026 (UTC)

Sameer Jauhar is a British psychiatrist and clinical academic. He is Clinical Associate Professor in Affective Disorders and Psychosis in the Division of Psychiatry, Department of Brain Sciences, at Imperial College London, and a Consultant Psychiatrist at the Brent Early Intervention Service, Central and North West London NHS Foundation Trust. He is known for research on schizophrenia, bipolar disorder, and antidepressants, and contributes to public and policy debate on psychopharmacology.[1]

Education

Jauhar was educated at Hutchesons' Grammar School in Glasgow. He studied at the University of Glasgow, graduating with a BSc in Medical Sciences (Epidemiology and Public Health) in 2000 and an MB ChB in 2002. He obtained his MRCPsych in 2007 and a Certificate of Completion of Training in general adult psychiatry and addictions in 2010. He completed a PhD at King's College London in 2018 and was elected Fellow of the Royal College of Psychiatrists (FRCPsych) in 2019.

Academic career

Jauhar held posts at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London from 2012. He was appointed Reader in Affective Disorders and Psychosis at IoPPN in September 2024. He joined Imperial College London in 2024 and is currently Clinical Associate Professor in Affective Disorders and Psychosis. He is also Co-Deputy Head of the Division of Psychiatry and EDI Lead (Clinical) in the Department of Brain Sciences.

Clinically, he has served as a Consultant Psychiatrist in the South London and Maudsley NHS Foundation Trust Early Intervention in Psychosis pathway since 2019, and joined Central and North West London NHS Foundation Trust as Consultant at the Brent Early Intervention Service in March 2025.

Research

Jauhar's research spans schizophrenia, bipolar disorder, and the pharmacology of antidepressants. He is first author of a 2022 Lancet Seminar on schizophrenia, one of the journal's comprehensive reviews of a major disease area.[2]

He has published studies on dopamine and mood in psychotic disorders and on antidepressant discontinuation in JAMA Psychiatry.[3][4] He has commented publicly on debates about the serotonin hypothesis of depression and the evidence base for antidepressants.[1][5]

He chairs the British Association for Psychopharmacology (BAP) working group developing updated guidelines on schizophrenia and has served on the BAP Council.[6] He is an expert adviser to NICE on schizophrenia and psychopharmacology, and has chaired a group on bipolar diagnosis at the Royal College of Psychiatrists (RCPsych), where he also serves on the Executive of the Academic Faculty.

Public engagement

Jauhar has appeared regularly in national media as a commentator on psychiatry and psychopharmacology. He has been quoted in The Guardian,[7] The New York Times,[5] Nature,[1] NPR,[8] and the Los Angeles Times,[9] among others. He has appeared on BBC television and radio and has contributed expert reactions through the Science Media Centre.[10][full citation needed]

He served as a psychiatric consultant to the BBC documentary What's the Matter with Tony Slattery? (2020), which examined the actor and comedian Tony Slattery's experiences of mental illness.[11]

Awards

Jauhar was awarded the International College of Neuropsychopharmacology (CINP) Rafaelsen Young Investigator Award in 2022.[12] The award is given at the CINP World Congress to recognise contributions to neuropsychopharmacology by early-career researchers. He was awarded the BAP Public Communication Prize in 2024.[13]

Selected publications

  • Jauhar, Sameer; Johnstone, Mandy; McKenna, Peter J (January 2022). "Schizophrenia". The Lancet. 399 (10323): 473–486. doi:10.1016/S0140-6736(21)01730-X. PMID 35093231 Check |pmid= value (help).
  • Jauhar, Sameer; McCutcheon, Robert A.; Nour, Matthew M.; Veronese, Mattia; Rogdaki, Maria; Bonoldi, Ilaria; Azis, Matilda; Whitehurst, Thomas; Arumuham, Atheeshaan; Onwordi, Ellis; Turkheimer, Federico; McGuire, Philip; Young, Allan H.; Howes, Oliver D. (October 2025). "Dopamine and Mood in Psychotic Disorders: An 18 F-DOPA PET Study". JAMA Psychiatry. 82 (10): 1009–1014. doi:10.1001/jamapsychiatry.2025.1811. ISSN 2168-622X. PMC 12351467 Check |pmc= value (help). PMID 40802251 Check |pmid= value (help).
  • Kalfas, Michail; Tsapekos, Dimosthenis; Butler, Matthew; McCutcheon, Robert A.; Pillinger, Toby; Strawbridge, Rebecca; Bhat, Bhagyashree Bhaskar; Haddad, Peter M.; Cowen, Philip J.; Howes, Oliver D.; Joyce, Dan W.; Nutt, David J.; Baldwin, David S.; Pariante, Carmine M.; Lewis, Gemma (September 2025). "Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis". JAMA Psychiatry. 82 (9): 896–904. doi:10.1001/jamapsychiatry.2025.1362. ISSN 2168-622X. PMC 12242823 Check |pmc= value (help). PMID 40632531 Check |pmid= value (help).
  • Jauhar, Sameer; Arnone, Danilo; Baldwin, David S.; Bloomfield, Michael; Browning, Michael; Cleare, Anthony J.; Corlett, Phillip; Deakin, J. F. William; Erritzoe, David; Fu, Cynthia; Fusar-Poli, Paolo; Goodwin, Guy M.; Hayes, Joseph; Howard, Robert; Howes, Oliver D. (August 2023). "A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression". Molecular Psychiatry. 28 (8): 3149–3152. doi:10.1038/s41380-023-02095-y. ISSN 1359-4184. PMC 10618084 Check |pmc= value (help). PMID 37322065 Check |pmid= value (help).

References

  1. ↑ 1.0 1.1 1.2 Peeples, Lynne (27 August 2026). "The baffling science of SSRIs: how do they really work?". Nature. 656 (8129): 812–814. Bibcode:2026Natur.656..812P. doi:10.1038/d41586-026-02570-w. ISSN 0028-0836. PMID 42649396 Check |pmid= value (help).
  2. ↑ Jauhar, Sameer; Johnstone, Mandy; McKenna, Peter J (January 2022). "Schizophrenia". The Lancet. 399 (10323): 473–486. doi:10.1016/S0140-6736(21)01730-X. PMID 35093231 Check |pmid= value (help). Archived from the original on 12 September 2025. Retrieved 5 November 2026. Unknown parameter |url-status= ignored (help)
  3. ↑ Jauhar, Sameer; McCutcheon, Robert A.; Nour, Matthew M.; Veronese, Mattia; Rogdaki, Maria; Bonoldi, Ilaria; Azis, Matilda; Whitehurst, Thomas; Arumuham, Atheeshaan; Onwordi, Ellis; Turkheimer, Federico; McGuire, Philip; Young, Allan H.; Howes, Oliver D. (October 2025). "Dopamine and Mood in Psychotic Disorders: An 18 F-DOPA PET Study". JAMA Psychiatry. 82 (10): 1009–1014. doi:10.1001/jamapsychiatry.2025.1811. ISSN 2168-622X. PMC 12351467 Check |pmc= value (help). PMID 40802251 Check |pmid= value (help).
  4. ↑ Kalfas, Michail; Tsapekos, Dimosthenis; Butler, Matthew; McCutcheon, Robert A.; Pillinger, Toby; Strawbridge, Rebecca; Bhat, Bhagyashree Bhaskar; Haddad, Peter M.; Cowen, Philip J.; Howes, Oliver D.; Joyce, Dan W.; Nutt, David J.; Baldwin, David S.; Pariante, Carmine M.; Lewis, Gemma (September 2025). "Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis". JAMA Psychiatry. 82 (9): 896–904. doi:10.1001/jamapsychiatry.2025.1362. ISSN 2168-622X. PMC 12242823 Check |pmc= value (help). PMID 40632531 Check |pmid= value (help).
  5. ↑ 5.0 5.1 Rabin, Roni Caryn (9 July 2025). "New Research Questions Severity of Withdrawal From Antidepressants". The New York Times. Archived from the original on 18 January 2026. Retrieved 4 November 2026. Unknown parameter |url-status= ignored (help)
  6. ↑ "Sameer Jauhar". Imperial College London.
  7. ↑ Bawden, Anna (5 June 2024). "Antidepressant withdrawal symptoms experienced by 15% of users, study finds". The Guardian.
  8. ↑ Stone, Will (13 July 2025). "A new study renews the debate around withdrawal from stopping antidepressants". NPR. Archived from the original on 22 October 2026. Retrieved 4 November 2026. Unknown parameter |url-status= ignored (help)
  9. ↑ Burrin, Elliot (14 July 2025). "Going off antidepressants causes fewer symptoms than previously thought, according to a new study". Los Angeles Times. Bloomberg. Archived from the original on 12 November 2025. Retrieved 4 November 2026. Unknown parameter |url-status= ignored (help)
  10. ↑ "Family therapy and hospital admissions study". BBC. 27 August 2025.
  11. ↑ "Tony Slattery 'moved' by reaction to documentary". BBC News. 22 May 2020. Archived from the original on 28 April 2025. Retrieved 5 November 2026. Unknown parameter |url-status= ignored (help)
  12. ↑ Dr. Sameer Jauhar – Rafaelsen Young Investigator Award Winner. International College of Neuropsychopharmacology. 29 September 2022. Archived from the original on 30 May 2023. Retrieved 4 November 2026 – via YouTube. Unknown parameter |url-status= ignored (help)
  13. ↑ "Annual Report and Accounts — British Association for Psychopharmacology". Charity Commission for England and Wales. 2024.


Category:Living people Category:British psychiatrists Category:Academics of Imperial College London Category:Academics of King's College London Category:Alumni of the University of Glasgow Category:Fellows of the Royal College of Psychiatrists Category:People educated at Hutchesons' Grammar School Category:Psychopharmacologists


This article "Sameer Jauhar" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Sameer Jauhar. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.


Retrieved from "https://en.everybodywiki.com/index.php?title=Sameer_Jauhar&oldid=6968279"
License CC BY-SA 3.0
Powered by MediaWiki